APG-101.10

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAPG-101.10
Drug Alias Name101.1IL-1 receptor inhibitor (Allostera)AllosteramerAPG-101.10
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Retinal DiseasesGout +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllostera Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllostera Pharma
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Retinal DiseasesGout +[4] 

Other Information

ATC CodeN/A
Related LinksN/A